Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ocrelizumab may cause pancreatitis in some patients.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Researchers found several compounds that could potentially treat Zika virus.

Compound 4 is a promising treatment for hair loss with low toxicity.